J&J agrees to pay drug import fine
Johnson & Johnson will pay more than $500,000 in fines after the federal government found that the company did not adhere to the Controlled Substances Act when it failed to report the importation of medications.
- ICD-10 Delay Alters Provider, Vendor Prep
- Providers Lag as Consumers Set Agenda
- Payment Reform Naysayers 'Better Wake Up'
- As Hospitalist Patient Loads Rise, So Do Hospital Costs
- HIT Leaders Want Flexibility, Transparency from Next HHS Chief
- Crisis Spurs Healthcare Payment Reform in Arkansas
- Esther Dyson Launches Population Health Challenge
- Reduce Readmissions by Activating Patients to Do 'Self-Care'
- Advance Directives: Let's Make a Law
- Hire Care Coordinators Strategically